Pulmonx Corporation (NASDAQ: LUNG) reported Q4 EPS of ($0.25), $0.14 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $22.59 million versus the consensus estimate of $23.21 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.